Assignee
ETNOVA THERAPEUTICS CORP
KR·3 granted patents·1 pending application·2 citations·filing 2019–2023
Top patents by PatentIndex Score
4 records- 0171US12098147B2Compound having novel structure, complex comprising same, anti-cancer pharmaceutical composition, and anti-cancer drugETNOVA THERAPEUTICS CORP·Filed 2019·Granted Sep 24, 2024·2 cites·19 claims
- 0253US2025281503A1Do3a-based antithrombotic agent or hemolytic agent containing gadolinium complexETNOVA THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 0342US12551468B2Pharmaceutical composition for oral administration, for treatment of liver cancerETNOVA THERAPEUTICS CORP·Filed 2020·Granted Feb 17, 2026·0 cites·11 claims
- 0442US12404255B2Compound and pharmaceutical composition containing same for treating or preventing neural damage, neural disease, or developmental disorder through promoting proliferation, differentiation, and/or regeneration of neural cellsETNOVA THERAPEUTICS CORP·Filed 2020·Granted Sep 2, 2025·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when ETNOVA THERAPEUTICS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →